Noninvasive assessment of characteristics of novel anti-HER2

Biparatopic anti-HER2 drug radioconjugates as breast cancer theranostics

New Approach May Help Predict HER2+ Tumor Response to Treatment – Consult QD

Binding assay of the purified anti-HER2 scFv expressed from BL21 (DE3)

Combination Therapies for Advanced Biliary Tract Cancer

Hierarchically Structured Molecularly Imprinted Nanotransducers for Truncated HER2-Targeted Photodynamic Therapy of Therapeutic Antibody-Resistant Breast Cancer

Competitive binding assay of Trastuzumab and anti-HER2 scFv to HER2.

Clinical and translational relevance of intratumor heterogeneity: Trends in Cancer

Cancers, Free Full-Text

Noninvasive assessment of characteristics of novel anti-HER2 antibodies by molecular imaging in a human gastric cancer xenograft-bearing mouse model

Extending traditional antibody therapies: Novel discoveries in immunotherapy and clinical applications - ScienceDirect

Combined Morphological and Spectroscopic Diagnostic of HER2 Expression in Breast Cancer Tissues Based on Label-Free Surface-Enhanced Raman Scattering

Immuno-PET Detects Changes in Multi-RTK Tumor Cell Expression Levels in Response to Targeted Kinase Inhibition

Clinicopathological characteristics of the study population with

124I-labeled anti-CD147 antibody for noninvasive detection of CD147-positive pan-cancers: construction and preclinical studies